2.36
0.05 (2.16%)
0.05 (2.16%)
Upgrade to Real-Time
Afterhours
Low
2.15
High
5.84
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.05 | 2.16% | 2.36 | 18:04:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.37 | 2.30 | 2.4341 | 2.36 | 2.31 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.30 | 2.45 | 0.15 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 538 | 139,747 | $ 2.35 | $ 327,832 | - | 2.15 - 5.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:48:29 | 7 | $ 2.43 | USD |
Period:
Draw Mode:
Acer Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 33.77M | 14.31M | 9.44M | $ - | $ - | -2.06 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 223.57k | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.29 | 2.65 | 2.28 | 2.42 | 178,809 | 0.07 | 3.06% |
| 1 Month | 2.95 | 2.9795 | 2.28 | 2.52 | 95,063 | -0.59 | -20.0% |
| 3 Months | 2.82 | 3.14 | 2.28 | 2.74 | 86,771 | -0.46 | -16.31% |
| 6 Months | 3.78 | 5.39 | 2.28 | 3.72 | 454,595 | -1.42 | -37.57% |
| 1 Year | 3.65 | 5.84 | 2.15 | 3.68 | 513,973 | -1.29 | -35.34% |
| 3 Years | 20.07 | 34.10 | 1.08 | 4.78 | 246,732 | -17.71 | -88.24% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.09 | 197,681 | -6.19 | -72.4% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
